CCDC137P

Across TCGA pan-cancer cohorts, CCDC137P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated CCDC137P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher CCDC137P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCDC137P expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

MESO, ACC, and LUSC are the cancer types where CCDC137P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.181	0.404	<.001	108	view →
ACC	DFS	Tertile	IV	0.012	0.310	.002	81	view →
LUSC	OS	Tertile	III,IV	0.079	0.803	<.001	54	view →
HNSC	DFS	Tertile	III,IV	0.575	0.280	.007	36	view →
LAML	DFS	Median	All	0.403	0.713	.002	36	view →
COAD	DFS	Tertile	IV	0.278	0.529	.018	27	view →
LIHC	DFS	Tertile	II,III,IV	0.064	0.471	<.001	21	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
LGG	OS	Tertile	All	0.270	0.468	.001	18	view →
UCS	DFS	Median	IV	0.438	0.812	.033	18	view →
UVM	DFS	Tertile	III,IV	0.079	0.635	.021	9	view →
THCA	OS	Tertile	IV	0.813	1.000	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

CCDC137P–MESO (DFS)

Open the MESO breakdown →